GridcoinStats uses the popular blockchain based blogging platform Steemit to relay news and updates. To read the full article, comment and vote please browse to it by clicking on the title.
Here you can read our latest headlines about the page, as well as the latest headlines in the "gridcoin" category, both from Steemit.com
All the current Whitelisted Projects news feeds are collected on this page as well, which uses their respective forums.
Posts from the Commutiy that are made in sub-categories for a Gridcoin whitelisted project. Read more project specific news on each projects page in the Projects Section
Headlines from projects on the whitelist. Read more by clicking the link, commenting usually possible on respective projects forum. More headlines on each projects details page by clicking on the project name below the article.
As you know, I'm working on Universe@Home for some years now. I was also one of creators and admins of Radioactive@Home project and few another BOINC projects.
Unfortunately, for long time I'm working on this project voluntarily as is no funds on it to my role.
Because of this, I will ask you for support on my [Link] Patreon profile.
The LHC@home BOINC servers will be upgraded to the [Link] latest BOINC server release Tuesday morning at 8AM GMT. BOINC services like upload/download and task validation and assimilation will be paused for about 1 hour during the intervention to update our servers.
By lhc@home classic
New record for the decic app
The decic app has completed its biggest search yet, the one over Q(√-2), dataset 13x271. This batch had almost 5 million WUs. Total run time summed over all hosts was 2890 years. It unearthed a total of 148 unique fields. Good job everyone!
I am sending a new experiment on the short queue targeting inhibitor of apoptosis proteins.
Inhibitor of apoptosis proteins (IAPs) constitute a family of conserved protein in the apoptotic pathway. In other words, they prevent the "programmed death" of cells; therefore, their over-expression enhances survival and resistance to anticancer agents. Small molecules (smac mimetics, SM), similar to the natural antagonist of IAPs, are a first generation of drugs which have been developed to sensitize cells to apoptosis. Although they are currently used in cancer therapy, there are some cases in which the SM-mediated degradation brings to the non canonical activation of NFkb and so to the expression of CIAP2 gene, suppressing TNF-alpha killing; in other words, resistance may arise to SM. In this set of simulations we are testing some mechanisms with which apoptosis in resistant cancer cells may be restored.
The WUs are tagged "*IAP*".